Frequent MAGE Mutations in Human Melanoma

• Otavia L. Caballero ,

  Contributed equally to this work with: Otavia L. Caballero, Qi Zhao

  * E-mail: ocaball1@jhmi.edu

  Current address: Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  Affiliation Ludwig Institute for Cancer Research Ltd, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Qi Zhao ,

  Contributed equally to this work with: Otavia L. Caballero, Qi Zhao

  Affiliation J. Craig Venter Institute, Rockville, Maryland, United States of America

  ⨯
• Donata Rimoldi,

  Affiliation Ludwig Institute for Cancer Research Ltd, Lausanne Branch, Lausanne, Switzerland

  ⨯
• Brian J. Stevenson,

  Affiliation Ludwig Institute for Cancer Research Ltd, Lausanne Branch, Lausanne, Switzerland

  ⨯
• Suzanne Svobodová,

  Affiliation Ludwig Institute for Cancer Research Ltd, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia

  ⨯
• Sylvie Devalle,

  Affiliation Ludwig Institute for Cancer Research Ltd, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Ute F. Röhrig,

  Affiliation Ludwig Institute for Cancer Research Ltd, Lausanne Branch, Lausanne, Switzerland

  ⨯
• Anna Pagotto,

  Affiliation Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research Ltd, Oxford Branch, Headington, Oxford, United Kingdom

  ⨯
• Olivier Michielin,

  Affiliation Ludwig Institute for Cancer Research Ltd, Lausanne Branch, Lausanne, Switzerland

  ⨯
• Daniel Speiser,

  Affiliation Ludwig Institute for Cancer Research Ltd, Lausanne Branch, Lausanne, Switzerland

  ⨯
• Jedd D. Wolchok,

  Affiliations Ludwig Institute for Cancer Research Ltd, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Medicine and Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Cailian Liu,

  Affiliation Department of Medicine and Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Tanja Pejovic,

  Affiliation Division of Gynecologic Oncology and the Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Kunle Odunsi,

  Affiliation Department of Gynecological Oncology and Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Francis Brasseur,

  Affiliation Ludwig Institute for Cancer Research Ltd, Brussels Branch, Université catholique de Louvain, Brussels, Belgium

  ⨯
• Benoit J. Van den Eynde,

  Affiliation Ludwig Institute for Cancer Research Ltd, Brussels Branch, Université catholique de Louvain, Brussels, Belgium

  ⨯
• Lloyd J. Old,

  Affiliation Ludwig Institute for Cancer Research Ltd, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Xin Lu,

  Affiliation Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research Ltd, Oxford Branch, Headington, Oxford, United Kingdom

  ⨯
• Jonathan Cebon,

  Affiliation Ludwig Institute for Cancer Research Ltd, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia

  ⨯
• Robert L. Strausberg,

  Affiliation Ludwig Institute for Cancer Research Ltd, New York, New York, United States of America

  ⨯
•  [ ... ],
• Andrew J. Simpson

  Affiliation Ludwig Institute for Cancer Research Ltd, New York, New York, United States of America

  ⨯
• [ view all ]
• [ view less ]